Financial Assistance | INBRACE Support Program | INGREZZA . . . The INGREZZA Savings Program, Patient Assistance Program, and Medicare Extra Help Program may be available to help your patients start and stay on treatment $10 or less out-of-pocket is what most patients pay for INGREZZA 1
Support for HD Chorea | INGREZZA® (valbenazine) capsules The INGREZZA Patient Assistance program is designed to provide support for patients who have no insurance, those with insurance but lacking prescription coverage for INGREZZA, or who demonstrate a qualifying financial need If eligible, your patient will receive their medications at no cost † † Additional terms and conditions apply
INBRACE® Support | INGREZZA® (valbenazine) capsules | HCP Depression and Suicidality in Patients with Huntington’s Disease: VMAT2 inhibitors, including INGREZZA and INGREZZA SPRINKLE, can increase the risk of depression and suicidal thoughts and behavior (suicidality) in patients with Huntington’s disease Balance the risks of depression and suicidality with the clinical need for treatment of chorea
Ingrezza Patient Assistance Program - Requirements Forms (2025) The Ingrezza Patient Assistance Program offers significant benefits for patients requiring Ingrezza or Ingrezza Sprinkle By participating in the Ingrezza Patient Assistance Program, eligible patients in the United States or US Territories may receive their medication at no cost, provided they meet specific criteria related to residency, prescription coverage, and income
Ingrezza (Valbenazine) Patient Assistance Program As the fastest growing pharmacy program in the country, Prescription Hope can obtain Ingrezza for individuals at the set price of $60 00 per month To obtain prescription medications, Prescription Hope works directly with over 180 pharmaceutical manufacturers and their pharmacy to obtain Ingrezza at a set, affordable price
Ingrezza Start Form – Enrollment in INBRACE Support Program Patients, prescribers, and specialty pharmacies often require the Ingrezza Start Form to enrol Ingrezza-prescribed patients in the Inbrace Support program The Ingrezza patient assistance form helps reduce treatment costs for Tardive dyskinesia (G24 01) and Huntington’s chorea (G10)
Patients and Caregivers | INBRACE Support Program | INGREZZA . . . We are here to help you every step of the way—from letting you know what to expect when your doctor sends your INGREZZA prescription to the pharmacy, to providing information about options to help pay for INGREZZA Download the Patient Overview to assist you in understanding enrollment in the INBRACE Support Program and getting started with
INGREZZA® - PANTHERx Rare Inbrace Support Program EXPLORE 7x Winner of the MMIT Patient Choice Award! Give us a call 855 726 8479 INGREZZA® (valbenazine) is indicated for the
Ingrezza Sprinkle Prices, Coupons, Copay Cards Patient . . . **Physicians apply for this program on behalf of their patients Co-payment assistance, reimbursement support, and patient assistance programs are available for eligible patients Applicable drugs: Ingrezza Sprinkle (valbenazine) Capsule More information please phone: 844-647-3992 Visit Website
PATIENT TREATMENT resources - INGREZZA (valbenazine) capsules . . . The most common side effects of INGREZZA or INGREZZA SPRINKLE in people with chorea associated with Huntington’s disease include sleepiness and tiredness, raised itchy red areas on your skin (hives), rash, and trouble getting to sleep or staying asleep These are not all of the possible side effects of INGREZZA or INGREZZA SPRINKLE
Ingrezza Patient Financial Assistance Programs Find all of the current financial assistance and savings programs for Ingrezza , and preview how much your patients could save Explore ways to make costly prescriptions more affordable
PATIENT ASSISTANCE PROGRAM - INBRACE Support Program PATIENT ASSISTANCE PROGRAM To be completed in full, signed, and dated, then faxed to 844-394-7155 For additional assistance, call 84-INGREZZA (844-647-3992), 8 am – 8 pm EST, M – F APPLICATION • Only completed INGREZZA Patient Assistance Program Applications will be reviewed for patient program eligibility